Elanco Animal Health
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.5% | 15.2% | 0.2% | 16.9% | 15.7% | 17.4% | -0.3% | 19.1% | 19.3% | 9.4% | 0.9% | 20.2% | 12.3% | |
| 16.2% | 16.5% | 13.8% | 13.7% | 16.5% | 16.1% | 13.5% | 13.6% | 15.5% | 15.2% | 12.5% | 12.5% | 13.8% | |
| 0.9% | 1.4% | 0.9% | 1.2% | 1.5% | 1.5% | 1.3% | 1.6% | 1.5% | 1.4% | 1.5% | 1.5% | 1.5% | |
| 102.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.5% | 14.1% | -14.7% | 1.9% | 15.0% | -2.5% | -19.9% | 4.2% | -20.8% | 19.7% | -19.2% | 1.8% | -5.0% | |
| 3.1% | 4.0% | 2.0% | 2.9% | 4.1% | 5.2% | 5.4% | 4.6% | 8.1% | 5.4% | 3.7% | 2.4% | 4.7% | |
| -3.4% | -3.4% | 3.1% | -2.8% | 120.8% | -8.8% | -4.9% | -4.5% | -8.9% | -5.6% | -4.4% | -8.0% | -6.7% | |
| – | – | – | – | – | – | -1.1% | -0.1% | – | – | -2.5% | 2.5% | – | |
| -28.9% | – | – | – | -129.3% | -3.7% | 6.0% | -35.9% | -16.5% | -0.1% | -1.2% | -5.3% | -5.5% | |
| -14.7% | -13.4% | -2.2% | -7.9% | -130.1% | -3.1% | 4.4% | -12.6% | -13.5% | -1.6% | -4.7% | -5.4% | -6.2% | |
| 0.2% | -1.6% | -0.6% | 6.0% | 7.2% | -2.2% | 1.6% | 4.2% | -3.0% | 3.5% | -8.5% | 7.5% | -0.2% | |
| 15.4% | 11.2% | -1.8% | 14.0% | 11.7% | 12.2% | -5.8% | 14.5% | 11.2% | 4.0% | -2.8% | 17.8% | 7.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.